Eusol Biotech Co.,Ltd. (6652.TWO)
TWD 6.04
(-0.17%)
TWD 6.04
(-0.17%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.35 Million TWD | -30.52% |
| 2022 | 6.26 Million TWD | 25.69% |
| 2021 | 4.98 Million TWD | -36.16% |
| 2020 | 7.81 Million TWD | 1.67% |
| 2019 | 7.68 Million TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 402 Thousand TWD | 595.02% |
| 2024 Q1 | 402 Thousand TWD | -90.77% |
| 2023 Q4 | 4.35 Million TWD | 171.11% |
| 2023 FY | 4.35 Million TWD | -30.52% |
| 2023 Q3 | 1.6 Million TWD | -74.37% |
| 2023 Q2 | 6.26 Million TWD | 124.3% |
| 2023 Q1 | 2.79 Million TWD | -55.42% |
| 2022 Q4 | 6.26 Million TWD | 57.98% |
| 2022 FY | 6.26 Million TWD | 25.69% |
| 2022 Q3 | 3.96 Million TWD | 0.0% |
| 2021 FY | 4.98 Million TWD | -36.16% |
| 2020 FY | 7.81 Million TWD | 1.67% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 98.919% |
| Level Biotechnology Inc. | 13.5 Million TWD | 67.753% |
| Sagittarius Life Science Corp | 13.32 Million TWD | 67.32% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 95.506% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 99.42% |
| GlycoNex Incorporation | 900 Thousand TWD | -383.778% |
| VBI | - TWD | -Infinity% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 98.306% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 98.64% |
| Visgeneer Inc. | 158.6 Million TWD | 97.255% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 99.401% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 97.499% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | 19.831% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.779% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -271.819% |
| Enimmune corporation | 45.73 Million TWD | 90.48% |
| TaiRx, Inc. | 12.28 Million TWD | 64.561% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| EirGenix Inc. | 465.16 Million TWD | 99.064% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 92.52% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 98.888% |
| Lin BioScience, Inc. | 42.87 Million TWD | 89.844% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 66.743% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | 59.678% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 96.162% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 94.726% |
| RBC Bioscience Corporation | 487.36 Million TWD | 99.107% |
| BiOptic Inc. | 93.19 Million TWD | 95.328% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -21.214% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -709.294% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 69.711% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 99.361% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -214.823% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -105.96% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 98.465% |
| Neith Corporation | 3.54 Million TWD | -22.96% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -400.46% |
| NaviFUS Corp. | 32.69 Million TWD | 86.682% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 98.956% |
| Sinew Pharma Inc. | 6.46 Million TWD | 32.642% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 83.946% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 97.78% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 65.472% |
| AP Biosciences Inc | 82.07 Million TWD | 94.695% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.85% |
| 3D Global Biotech Inc. | 10.37 Million TWD | 58.05% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 96.984% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.697% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 98.906% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | 45.377% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | 26.178% |
| TCI GENE Inc. | 6.79 Million TWD | 35.923% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | 47.656% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | 54.651% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 98.379% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 59.24% |
| PharmaEngine, Inc. | 14.8 Million TWD | 70.599% |
| Savior Lifetec Corporation | 270.37 Million TWD | 98.39% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 94.17% |
| OBI Pharma, Inc. | 501.05 Million TWD | 99.131% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 87.209% |
| Acepodia, Inc. | 273.81 Million TWD | 98.41% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 78.717% |